Classes
- Extension of Practice and Selected Lectures in Gynecology and ObstetricsFG50040 | Faculty of Medicine in Hradec Králové
- Selected Topics from Gynecology and Obstetrics for Dentists +1FD50011 | Faculty of Medicine in Hradec Králové
- Gynecology and Obstetrics +3FFK1050 | Faculty of Medicine in Hradec Králové
- Practice and internshipsFPV50 | Faculty of Medicine in Hradec Králové
- Nursing in Gynecology +2FOP10038 | Faculty of Medicine in Hradec Králové
Publications
- Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression2024 | Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Surgical management of ovarian cancer2024 | Faculty of Medicine in Hradec Králové
- DNA methylation of selected tumor suppressor genes in endometrial hyperplasia2024 | Faculty of Medicine in Hradec Králové
- Surgical treatment of endometrial cancer2024 | Faculty of Medicine in Hradec Králové
- DNA hypermethylation of tumor suppressor genes TWIST1, GATA4, MUS81 and NTRK1 in endometrial hyperplasia2024 | Faculty of Medicine in Hradec Králové
- Ureteroarterial fistula - a severe manifestation of urological toxicity with possibly fatal consequences2024 | Faculty of Medicine in Hradec Králové
- Surgical treatment of malignant neoplasms cervix2024 | Publication without faculty affiliation
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Is there an association between pelvic organ prolapse and oxidative stress? A systematic review2022 | Faculty of Medicine in Hradec Králové
- Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial2021 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
Loading network view...
